104 related articles for article (PubMed ID: 9394998)
1. A case of dermatomyositis triggered by tegafur.
Akiyama C; Osada A; Sou K; Yasaka N; Ohtake N; Furue M; Tamaki K
Acta Derm Venereol; 1997 Nov; 77(6):490. PubMed ID: 9394998
[No Abstract] [Full Text] [Related]
2. A case of capecitabine-induced dermatomyositis.
Saraswat N; Verma R; Neema S; Kumar S
Indian J Pharmacol; 2018; 50(6):350-353. PubMed ID: 30783329
[TBL] [Abstract][Full Text] [Related]
3. Lethal leukoencephalopathy secondary to Tegafur, a 5-fluorouracil prodrug.
Sierra S; Luquin N; Carrato C
J Neurol Sci; 2015 Oct; 357(1-2):326-8. PubMed ID: 26242718
[No Abstract] [Full Text] [Related]
4. Dermatomyositis associated with capecitabine in the setting of malignancy.
Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY
J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983
[No Abstract] [Full Text] [Related]
5. Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
Rubiales AS; del Valle ML
Cancer; 1999 Apr; 85(8):1866-7. PubMed ID: 10223583
[No Abstract] [Full Text] [Related]
6. Tegafur-induced photosensitivity--evaluation of provocation by UVB irradiation.
Usuki A; Funasaka Y; Oka M; Ichihashi M
Int J Dermatol; 1997 Aug; 36(8):604-6. PubMed ID: 9329892
[No Abstract] [Full Text] [Related]
7. [Corneal epithelial disorder, lacrimal drainage obstruction, and conjunctivitis].
Kase S
Nihon Rinsho; 2015 Feb; 73 Suppl 2():490-3. PubMed ID: 25831809
[No Abstract] [Full Text] [Related]
8. S-1 for the treatment of gastrointestinal cancer.
Satoh T; Sakata Y
Expert Opin Pharmacother; 2012 Sep; 13(13):1943-59. PubMed ID: 22860709
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Rectal Metastasis of Gastric Cancer Associated with Dermatomyositis].
Nishikawa K; Matsuda C; Kawada J; Fujitani K; Endo S; Hirao M; Yamamoto K; Maeda S; Uemura M; Miyake M; Hama N; Miyamoto A; Ikeda M; Nakamori S; Sekimoto M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2401-2403. PubMed ID: 28133335
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic dermatomyositis triggered and exacerbated by oral 5-fluorouracil administration.
Kawachi Y; Koike Y; Kano T; Furuta J; Fujisawa Y; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
Eur J Dermatol; 2008; 18(2):195-6. PubMed ID: 18424388
[No Abstract] [Full Text] [Related]
11. Treatment of gastric cancer in Asia: the missing link.
Nishida T
Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
[No Abstract] [Full Text] [Related]
12. Chronic liver failure induced by long-term administration of tegafur: a case report.
Matsumoto M; Nakao K; Matsumoto H; Iwata K; Ohta Y; Kanai K; Takahashi K; Akima M
Hepatogastroenterology; 1998; 45(24):2372-5. PubMed ID: 9951926
[TBL] [Abstract][Full Text] [Related]
13. An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group.
Sugimachi K; Maehara Y; Horikoshi N; Shimada Y; Sakata Y; Mitachi Y; Taguchi T
Oncology; 1999 Oct; 57(3):202-10. PubMed ID: 10545788
[TBL] [Abstract][Full Text] [Related]
14. Black lunula caused by Tegafur.
Chen GY; Chao SC; Chen W
Acta Derm Venereol; 2004; 84(3):238-9. PubMed ID: 15202848
[No Abstract] [Full Text] [Related]
15. The Clinical Evaluation of Tegafur Gimeracil Oteracil Combined with THP and DDP for Second-Line Treatment of Advanced Cardiac Carcinoma.
Wang HF; Lv JQ
Cell Biochem Biophys; 2015 Jul; 72(3):695-9. PubMed ID: 25618173
[TBL] [Abstract][Full Text] [Related]
16. Tegafur-induced hyperpigmentation of the tongue.
Kim HS; Park YM; Kim HO; Lee JY
J Dermatol; 2010 Oct; 37(10):937-8. PubMed ID: 20860752
[No Abstract] [Full Text] [Related]
17. Chemotherapy-induced acral erythema due to Tegafur.
Bastida J; Díaz-Cascajo C; Borghi S
Acta Derm Venereol; 1997 Jan; 77(1):72-3. PubMed ID: 9059686
[No Abstract] [Full Text] [Related]
18. Recent development of anti-cancer drugs for treatment of GI malignancies in Japan.
Taguchi T
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():76-80. PubMed ID: 11890118
[No Abstract] [Full Text] [Related]
19. Cutaneous side-effects caused by Tegafur.
Revenga F
Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
[No Abstract] [Full Text] [Related]
20. [Effecacy of three-dimensional conformal radiation therapy combined with Tegafur for postoperative recurrent rectal carcinoma].
Liu XH; Li WL
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):299-301. PubMed ID: 21575504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
